210. 単心室症 Single Ventricle Clinical trials / Disease details
臨床試験数 : 49 / 薬物数 : 53 - (DrugBank : 23) / 標的遺伝子数 : 32 - 標的パスウェイ数 : 67
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03997097 (ClinicalTrials.gov) | June 1, 2022 | 18/6/2019 | Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease | Phosphodiesterase-type 5 Inhibitors in Adult and Adolescent Patients With Univentricular Heart Disease: a Multi-center, Randomized, Double Blind Phase III Study | Single-ventricle;Pulmonary Hypertension;Univentricular Heart | Drug: Sildenafil;Drug: Placebos | University Hospital, Montpellier | NULL | Not yet recruiting | 15 Years | 80 Years | All | 50 | Phase 3 | NULL |
| 2 | NCT01169519 (ClinicalTrials.gov) | April 2011 | 7/7/2010 | Sildenafil in Single Ventricle Patients | Safety, Pharmacokinetics and Hemodynamic Efficacy of Sildenafil in Single Ventricle Patients | Heart Disease | Drug: Sildenafil by injection | Duke University | NULL | Completed | 3 Months | 120 Months | All | 21 | Phase 1 | United States |
| 3 | JPRN-UMIN000005343 | 2011/01/01 | 01/04/2011 | Effect of sildenafil in patients with single ventricle physiology | Single ventricle physiology | Administration of sildenafil | Tokyo Women's Medical University | NULL | Recruiting | 3months-old | Not applicable | Male and Female | 30 | Not applicable | Japan |